Inogen, Inc. (INGN)
NASDAQ: INGN · IEX Real-Time Price · USD
9.25
+0.22 (2.44%)
At close: Jul 19, 2024, 4:00 PM
9.35
+0.10 (1.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.

Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories.

It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Inogen, Inc.
Inogen logo
Country United States
Founded 2001
IPO Date Feb 14, 2014
Industry Medical Devices
Sector Healthcare
Employees 834
CEO Kevin R. M. Smith

Contact Details

Address:
859 Ward Drive
Goleta, California 93111
United States
Phone 805-562-0500
Website inogen.com

Stock Details

Ticker Symbol INGN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001294133
CUSIP Number 45780L104
ISIN Number US45780L1044
SIC Code 3842

Key Executives

Name Position
Kevin R. M. Smith President, Chief Executive Officer and Director
Jason Somer Executive Vice President, General Counsel and Corporate Secretary
Dr. Stanislav Glezer M.D., MBA Executive Vice President of Research & Development and Chief Medical Officer
Michael J. Bourque Executive Vice President, Chief Financial Officer and Treasurer
Philip Corrin Senior Vice President of Operations and Supply Chain
Jennifer Yi Boyer Executive Vice President and Chief Human Resources Officer
Vijay Paliwal Senior Vice President of Enterprise Enablement
Grgoire Ramade Executive Vice President and Chief Commercial Officer

Latest SEC Filings

Date Type Title
Jul 3, 2024 8-K Current Report
Jun 12, 2024 S-8 Securities to be offered to employees in employee benefit plans
Jun 7, 2024 8-K Current Report
May 31, 2024 SD Form - SD
May 15, 2024 8-K Current Report
May 14, 2024 144 Filing
May 8, 2024 10-Q Quarterly Report
May 7, 2024 8-K Current Report
Apr 23, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Apr 18, 2024 ARS Filing